Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF‐Japan): One‐year safety and effectiveness analyses

by Takeshi Yamashita, Yukihiro Koretsune, Tomoko Nagao, Kazuhito Shiosakai
Published 2020-06-01

Safety and effectiveness of edoxaban in Japanese patients with nonvalvular atrial fibrillation: Final report of a two‐year postmarketing surveillance study (ETNA‐AF‐Japan)

by Takeshi Yamashita, Yukihiro Koretsune, Tomoko Nagao, Kazuhito Shiosakai
Published 2021-04-01

Postmarketing surveillance on clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF‐Japan): Three‐month interim analysis results

by Takeshi Yamashita, Yukihiro Koretsune, Mayumi Ishikawa, Kazuhito Shiosakai, Seiji Kogure
Published 2019-02-01

A New Baroreceptor Sensitivity-Restoring Ca-Channel Blocker Diminishes Age-Related Morning Blood Pressure Increase in Hypertensive Patients: Open-Label Monitoring of Azelnidipine T...

by Mitsunori Sugiyama, Kazuyuki Shimada, Kazuhito Shiosakai, Katsutoshi Hiramatsu, Masayuki Shirayama, Kazuomi Kario
Published 2010-01-01

Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan

by Motonobu Sakaguchi, Shinji Takahashi, Masahiko Kobayashi, Tomomi Kimura, Kazuhito Shiosakai, Yasuaki Takeda
Published 2012-09-01

G protein‐coupled receptor 119 agonist DS‐8500a effects on pancreatic β‐cells in Japanese type 2 diabetes mellitus patients

by Hirotaka Watada, Masanari Shiramoto, Shin Irie, Yasuo Terauchi, Yuichiro Yamada, Kazuhito Shiosakai, Yusuke Myobatake, Takashi Taguchi
Published 2019-01-01

An exploratory assessment of the applicability of direct-to-consumer genetic testing to translational research in Japan

by Masahiro Inoue, Shota Arichi, Tsuyoshi Hachiya, Anna Ohtera, Seok-Won Kim, Eric Yu, Masatoshi Nishimura, Kazuhito Shiosakai, Takeshi Ohira
Published 2021-07-01